Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis

The myocardin-related transcription factor/serum response factor (MRTF/SRF) pathway represents a promising therapeutic target to prevent fibrosis. We have tested the effects of new pharmacological inhibitors of MRTF/SRF signalling in a preclinical model of fibrosis. CCG-222740, a novel MRTF/SRF inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu-Wai-Man, Cynthia, Spencer-Dene, Bradley, Lee, Richard M. H., Hutchings, Kim, Lisabeth, Erika M., Treisman, Richard, Bailly, Maryse, Larsen, Scott D., Neubig, Richard R., Khaw, Peng T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428058/
https://www.ncbi.nlm.nih.gov/pubmed/28364121
http://dx.doi.org/10.1038/s41598-017-00212-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428058/
https://www.ncbi.nlm.nih.gov/pubmed/28364121
http://dx.doi.org/10.1038/s41598-017-00212-w

Ejemplares similares